Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $151.6900 (-1.24%) ($151.5400 - $154.2350) on Wed. Dec. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.08% (three month average) | RSI | 82 | Latest Price | $151.6900(-1.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV advances 3.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IVE(72%) IBB(75%) XLI(73%) VFMO(70%) VYM(70%) | Factors Impacting ABBV price | ABBV will decline at least -0.54% in a week (0% probabilities). VXX(-97%) BNDX(-50%) USO(-19%) UNG(-12%) TIP(-11%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.54% (StdDev 1.08%) | Hourly BBV | -3.1 () | Intraday Trend | -1.5% | | | |
|
5 Day Moving Average | $153.53(-1.2%) | 10 Day Moving Average | $152.45(-0.5%) | 20 Day Moving Average | $147.24(3.02%) | To recent high | -2.1% | To recent low | 10.2% | Market Cap | $267.624b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |